申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US06331521B1
公开(公告)日:2001-12-18
The invention relates to new polypeptide compounds represented by the following formula [I]:
wherein
R1 is hydrogen, etc,
R2 is hydrogen, etc,
R3 is hydrogen, etc, and
R4 is hydrogen, etc,
or a salt thereof which have antimicrobial activities (especially, antifungal activities), inhibitory activity on &bgr;-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal.
本发明涉及新的多肽化合物,其表示为以下式子[I]:其中R1为氢等;R2为氢等;R3为氢等;R4为氢等;或其盐,具有抗微生物活性(特别是抗真菌活性),对β-1,3-葡聚糖合酶的抑制活性,及其制备方法、包含其的药物组合物,以及用于预防和/或治疗包括人类或动物的肺孢子菌感染(例如肺孢子菌性肺炎)的传染病的方法。